Inventor · disambiguated record
David Moebius
Also filed as: MOEBIUS DAVID · MOEBIUS DAVID C
12 granted patents·4 pending applications·41 citations·filing 2012–2023
88Inventor score
Files withAMGEN INC6ONYX THERAPEUTICS INC5SYROS PHARMACEUTICALS INC3CYTOKINETICS INC1SHAIR MATTHEW D1
Top patents by PatentIndex Score
16 records- 0196US11299479B1Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2020·Granted Apr 12, 2022·8 cites·23 claims
- 0296US10899746B2Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2020·Granted Jan 26, 2021·5 cites·27 claims
- 0394US11780826B2Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2022·Granted Oct 10, 2023·2 cites·19 claims
- 0493US10723720B2Bisamide sarcomere activating compounds and uses therofAMGEN INC·Filed 2018·Granted Jul 28, 2020·7 cites·21 claims
- 0590US9434761B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted Sep 6, 2016·13 cites·20 claims
- 0683US2024158372A1Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 0779US10647744B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2016·Granted May 12, 2020·2 cites·38 claims
- 0873US10689367B2Triazole pyridyl compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 23, 2020·1 cites·30 claims
- 0973US9657057B2Dipeptide and tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2014·Granted May 23, 2017·2 cites·21 claims
- 1069US11078233B2Tripeptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·27 claims
- 1163USRE47302EPeptide epoxyketone immunoproteasome inhibitorsONYX THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·0 cites·31 claims
- 1262US9321713B2Hyperforin analogs, methods of synthesis, and uses thereofSHAIR MATTHEW D·Filed 2012·Granted Apr 26, 2016·1 cites·33 claims
- 1357US2022332708A1Sulfonamide compounds as cardiac sarcomere activatorsCYTOKINETICS INC·Filed 2022·Application pending·0 cites
- 1457US2021147431A1Pyrrolotriazine compounds and methods of inhibiting tam kinasesSYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1552US11040981B2Pyrrolotriazine compounds and methods of inhibiting TAM kinasesSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·0 cites·28 claims
- 1641US2020291018A1Tam kinase inhibitorsSYROS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Moebius files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →